Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled

NCT01699932 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

167

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Glimepiride+metformin (Amaryl M®) - HOE4900

Sponsor

Sanofi